# Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

> **NCT01431937** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** GSK2018682
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01431937
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-10
- **Primary completion:** 2011-03-29
- **Final completion:** 2011-03-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431937, "Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01431937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*